John Liles

John Liles

Company: Gilead Sciences

Job title: Director, Biology

Seminars:

Panel Discussion: Identifying & Validating a Novel Therapy to Complement SGLT2 Inhibitors 9:30 am

Defining the next wave of therapeutics discovery after SGLT2i to improve clinical outcomes Measuring incremental benefit of novel therapeutics in addition to SGLT2 inhibitors Optimizing a smart preclinical screening platform to monitor efficacy in addition to standard of care Considering innovative trial design and untraditional endpoints to demonstrate efficacy and meet regulatory requirementsRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.